HRTX - Heron Therapeutics, Inc. /de/ - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - HRTX (818033)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
5 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-11-17
HRTXForbes William PEVP, Chief Development OfficerP - Purchase$1.09+25,00079,000+46%+$27,250
2023-11-16
HRTXForbes William PEVP, Chief Development OfficerP - Purchase$0.94+50,00054,000>999%+$46,995
2023-11-16
HRTXCollard Craig ACEOP - Purchase$0.92+150,000186,496+411%+$137,970
2023-11-16
HRTXDuarte IRAEVP, CFOP - Purchase$0.89+85,00085,000New+$75,599
D
2023-07-21
HRTXMorgan AdamDirP - Purchase$1.37+2,486,7447,024,623+55%+$3,406,839

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top